Serveur d'exploration SRAS - Analysis (2020)

Index « AbsEn.i » - entrée « importance »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
implying < importance < important  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000020 (2020) M C Kriegmair [Allemagne] ; K F Kowalewski [Allemagne] ; B. Lange [Allemagne] ; A. Heininger [Allemagne] ; T. Speck [Allemagne] ; H. Haas [Allemagne] ; M S Michel [Allemagne][Urology in the corona-virus pandemic-a guideline 4/20].
000027 (2020) Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
000039 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000057 (2020) H Y Tian [République populaire de Chine][2019-nCoV: new challenges from coronavirus].
000109 (2020) Inder P. Singh [Inde] ; Shiv Gupta [Inde] ; Sanjay Kumar [Inde]Thiazole Compounds as Antiviral Agents: An Update.
000113 (2020) C. Gardiner [Canada] ; J. Veall [Canada] ; S. Lockhart [Canada]The use of UV fluorescent powder for COVID-19 airway management simulation training.
000138 (2020) Huilan Tu [République populaire de Chine] ; Sheng Tu [République populaire de Chine] ; Shiqi Gao [République populaire de Chine] ; Anwen Shao [République populaire de Chine] ; Jifang Sheng [République populaire de Chine]The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event
000162 (2020) Shanthi Narla [États-Unis] ; Alexis B. Lyons [États-Unis] ; Indermeet Kohli [États-Unis] ; Angeli E. Torres [États-Unis] ; Angela Parks-Miller [États-Unis] ; David M. Ozog [États-Unis] ; Iltefat H. Hamzavi [États-Unis] ; Henry W. Lim [États-Unis]The Importance of the Minimum Dosage Necessary for UVC Decontamination of N95 Respirators during the COVID-19 Pandemic.
000163 (2020) Eric Daniel Tenda [Oman] ; Mira Yulianti ; Moses Mazmur Asaf ; Reyhan Eddy Yunus ; Wita Septiyanti ; Vally Wulani ; Ceva Wicaksono Pitoyo ; Cleopas Martin Rumende ; Siti SetiatiThe Importance of Chest CT Scan in COVID-19.
000184 (2020) Naidi Yang [République populaire de Chine] ; Han-Ming Shen [République populaire de Chine]Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
000223 (2020) Furong Qi [République populaire de Chine] ; Shen Qian [République populaire de Chine] ; Shuye Zhang [République populaire de Chine] ; Zheng Zhang [République populaire de Chine]Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
000250 (2020) Miyu Moriyama [États-Unis] ; Walter J. Hugentobler ; Akiko Iwasaki [États-Unis]Seasonality of Respiratory Viral Infections.
000261 (2020) Cheng-I Wu [Pays-Bas] ; Pieter G. Postema [Pays-Bas] ; Elena Arbelo ; Elijah R. Behr ; Connie R. Bezzina [Pays-Bas] ; Carlo Napolitano ; Tomas Robyns ; Vincent Probst ; Eric Schulze-Bahr ; Carol Ann Remme [Pays-Bas] ; Arthur A M. Wilde [Pays-Bas]SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.
000270 (2020) Takeshi Arashiro [Japon] ; Satoshi Nakamura [Japon] ; Takahiro Asami [Japon] ; Hatsuko Mikuni [Japon] ; Emiyu Fujiwara [Japon] ; So Sakamoto [Japon] ; Ryotaro Miura [Japon] ; Yosuke Shionoya [Japon] ; Ryoichi Honda [Japon] ; Keiichi Furukawa [Japon] ; Akira Nakamura [Japon] ; Haruhisa Saito [Japon]SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise.
000317 (2020) Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France]Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
000412 (2020) Andrés E. Castillo [Chili] ; Bárbara Parra [Chili] ; Paz Tapia [Chili] ; Alejandra Acevedo [Chili] ; Jaime Lagos [Chili] ; Winston Andrade [Chili] ; Loredana Arata [Chili] ; Gabriel Leal [Chili] ; Gisselle Barra [Chili] ; Carolina Tambley [Chili] ; Javier Tognarelli [Chili] ; Patricia Bustos [Chili] ; Soledad Ulloa [Chili] ; Rodrigo Fasce [Chili] ; Jorge Fernández [Chili]Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile.
000445 (2020) Robin N. Thompson [Royaume-Uni]Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations
000474 (2020) Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000484 (2020) Marco Colizzi [Italie, Royaume-Uni] ; Riccardo Bortoletto ; Marta Silvestri ; Federica Mondini ; Elena Puttini ; Chiara Cainelli ; Rossella Gaudino [Italie] ; Mirella Ruggeri [Italie] ; Leonardo ZoccanteMedically unexplained symptoms in the times of Covid-19 pandemic: a case-report
000517 (2020) Ying Yan [République populaire de Chine] ; Le Chang [République populaire de Chine] ; Lunan Wang [République populaire de Chine]Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures.
000575 (2020) Salman Ali Khan [Pakistan] ; Komal Zia [Pakistan] ; Sajda Ashraf [Pakistan] ; Reaz Uddin [Pakistan] ; Zaheer Ul-Haq [Pakistan]Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "importance" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "importance" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    importance
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021